Omlin A, Cathomas R, von Amsberg G, Reuter C, et al. Randomized phase 2 Cabazitaxel dose individualization and Neutropenia prevention Trial (CAINTA) in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res 2023 Mar 14:CCR-22-3360. doi: 10.1158/1078-0432.CCR-22-3360.
PMID: 36917691